Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2007, Vol. 110, No. 6, pp. 1989-1996.
Prepublished online as a Blood First Edition Paper on June 1, 2007; DOI 10.1182/blood-2006-10-054064.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-10-054064v1
110/6/1989    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nardi, M. A
Right arrow Articles by Karpatkin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nardi, M. A
Right arrow Articles by Karpatkin, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 26, 2006
Accepted May 29, 2007

Platelet particle formation by anti-GPIIIa49-66 Ab, Ca2+ lonophore A23187 and phorbol myristate acetate (PMA) is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2 (PLA2), 12-lipoxygenase(12-LO) and NADPH Oxidase

Michael A Nardi, Yelena Gor, Steven J Feinmark, Fang Xu, and Simon Karpatkin*

Department of Pediatrics, New York University School of Medicine, New York, NY, United States
Department of Pharmacology, Center for Molecular Therapeutics, Columbia College of Physicians and Surgeons, New York, NY, United States
Department of Anesthesia, New York University School of Medicine, New York, NY, United States
Department of Medicine, New York University School of Medicine, New York, NY, United States

* Corresponding author; email: simon.karpatkin{at}med.nyu.edu.

An HIV Ab against platelet integrin GPIIIa49-66 induces complement independent platelet formation by the elaboration of reaction oxygen species (ROS) downstream of the activation of the platelet NADPH oxidase by the 12-lipoxygenase (12-LO) product, 12(S)HETE. To determine whether other inducers of platelet particle formation also fuction via the induction of ROS, we examined the effects of the Ca2+ ionophore, A23187 and phorbol myristate acetate (PMA). Both agents induced oxidative platelet particle formation in an identical fashion as Ab, requiring Ca2+ flux, and 12(S) HETE production as well as intact NADPH oxidase and 12-LO pathways. Since HIV-ITP patients with this Ab correct their platelet counts with Dexamethasone (Dex) we examined the role of Dex in this unique autoimmune disorder. Dex at therapeutic concentrations inhibited Ab, A23187 or PMA-induced platelet particle formation by inhibiting platelet PLA2, 12-LO and NADPH oxidase. The operational requirement of translocation of PLA2, 12-LO and NADPH oxidase components (p67 phox) from cytosol to membrane for induction of reactive oxygen species (ROS) was both inhibited and partially reversed by Dex in platelets. We conclude that: 1) Platelet particle formation can be induced by the generation of ROS. 2) Platelet PLA2, 12-LO, NADPH oxidase and cytosol membrane translocation requirements for ROS production, are inhibited by Dex.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Z. Li, M. A. Nardi, Y.-S. Li, W. Zhang, R. Pan, S. Dang, H. Yee, D. Quartermain, S. Jonas, and S. Karpatkin
C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke
Blood, June 11, 2009; 113(24): 6051 - 6060.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Zhang, M. A. Nardi, W. Borkowsky, Z. Li, and S. Karpatkin
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia
Blood, April 23, 2009; 113(17): 4086 - 4093.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Guasti, F. Marino, M. Cosentino, R. C. Maio, E. Rasini, M. Ferrari, L. Castiglioni, C. Klersy, G. Gaudio, A. M. Grandi, et al.
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up
Eur. Heart J., May 1, 2008; 29(9): 1118 - 1126.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020